Cost-effectiveness of screening for and treating albuminuria in individuals without diabetes or hypertension: are we moving beyond the evidence?
Mangione
Filippo
F
Esposito
Ciro
C
Dal Canton
Antonio
A
D000419:Albuminuria / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000191:economics*; D003362:Cost-Benefit Analysis; D003920:Diabetes Mellitus / Q000175:diagnosis; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis; D007676:Kidney Failure, Chronic / Q000517:prevention & control*; D008297:Male; D008403:Mass Screening / Q000191:economics*; D012720:Severity of Illness Index
D000806:Angiotensin-Converting Enzyme Inhibitors